8 - Opening Plenary Session: From Outbreaks to -Omics: Revolutionizing the Infectious Diseases Landscape in the Age of Big Data

10/2/2019

3:45 PM - 5:15 PM

Room: Walter E. Washington Convention Center, Ballroom ABC (3rd Floor)

MOC Credit: Maximum of 1.0 hours of MOC Credit
CME Credit: Maximum of 1.0 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.5 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-316-L04-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe recent advances in the field of genomics and how they are accelerating research in a broad range of applications
examine the implications of these advances for the diagnosis, treatment, and prevention of infectious diseases and other disorders around the globe
list the ways in which genomic information can be used in response to emerging epidemics
recognize the advantages of novel CRISPR-based diagnostics in combatting infectious disease outbreaks, which include direct detection from non-invasive bodily fluids, visual read-out requiring only a heat block for equipment, rapid assay development in response to an emerging outbreak, and SNP detection

Presentations:

4:15 PM - 4:45 PM
25 - How Genomics is Revolutionizing Biomedicine Across Disciplines, Across Continents
Francis S. Collins, MD, PhD – National Institutes of Health
4:45 PM - 5:15 PM
26 - Outbreak Response in the Genomic and Information Age
Pardis C. Sabeti, MD, PhD – Harvard TH Chan School of Public Health

Moderator(s)

Cesar Arias, MD, MSc, PhD

Professor
University of Texas Health Science Center
Houston, TX

Disclosure: American Society for Microbiology: Fees for Editor of Antimicrobial Agents and Chemotherapy. Money paid to University, Other Financial or Material Support
Entasis Pharmaceuticals: Grant/Research Support, Research Grant
MeMed Diagnostics: Grant/Research Support, Research Grant
Merck: Grant/Research Support, Research Grant
UptoDate: Other Financial or Material Support, Royalties from a Chapter
Inger Damon, MD, PhD

Director Division of High Consequence Pathogens and Pathology
Centers for Disease Control and Prevention
Atlanta, Georgia

Disclosure: Nothing to disclose

Speaker(s)

Francis Collins, MD, PhD

Director
National Institutes of Health
Bethesda, MD
Pardis Sabeti, MD, PhD

Professor
Harvard TH Chan School of Public Health
Cambridge, MA

Disclosure: NextGenJane: Advisory Board, Investor in the Company and SAB member, Shareholder
Sherlock Biosciences: Consultant, Founder and Consultant, Shareholder